REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $843 | -99.9% | 45,659 | +6.2% | 0.10% | +18.0% |
| Q2 2022 | $594,000 | -54.7% | 42,978 | -36.1% | 0.09% | -49.4% |
| Q1 2022 | $1,311,000 | +80.6% | 67,232 | +174.4% | 0.18% | +114.6% |
| Q2 2021 | $726,000 | +60.6% | 24,498 | -19.9% | 0.08% | -27.4% |
| Q1 2020 | $452,000 | +115.2% | 30,574 | +192.5% | 0.11% | +370.8% |
| Q4 2018 | $210,000 | -48.3% | 10,451 | -29.4% | 0.02% | +20.0% |
| Q2 2018 | $406,000 | – | 14,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |